Rapport Therapeutics (RAPP) Other Non-Current Assets (2023 - 2026)
Rapport Therapeutics (RAPP) reported Other Non-Current Assets of $1.1 million for Q1 2026, up 400.95% year-over-year from $211000.0 in Q1 2025, and up 7.31% quarter-over-quarter from $985000.0 in Q4 2025.
Rapport Therapeutics (RAPP) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Other Non-Current Assets data on file, last reported at $1.1 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $1.1 million, up 400.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 400.95% YoY), and the FY2025 annual result was $985000.0, up 515.62% from the prior year.
- Other Non-Current Assets advanced to $1.1 million in Q1 2026 per RAPP's latest filing, from $985000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $1.1 million in Q3 2025 and troughed at $160000.0 in Q4 2024.
- A 4-year average of $604888.9 and a median of $551000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets plunged 70.96% in 2024, then jumped 515.62% in 2025.
- A 4-year view of Other Non-Current Assets shows it stood at $551000.0 in 2023, then sank by 70.96% to $160000.0 in 2024, then jumped by 515.62% to $985000.0 in 2025, then gained by 7.31% to $1.1 million in 2026.
- Business Quant data shows RAPP's Other Non-Current Assets at $1.1 million in Q1 2026, $985000.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 985,000.00 |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 211,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | 189,000.00 |
| Jun 30, 2024 | 189,000.00 |
| Dec 31, 2023 | 551,000.00 |